ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2015

Jan 15, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2013-10-09

Reporting Person: Ferrari Mauro (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-10-09	Common Stock	P	1900	$6.19	Acquired	3851	Direct
2013-10-28	Common Stock	P	400	$7.6176	Acquired	4251	Direct